Global Oncology

In a breast clinic in Africa, fear often arrives before diagnosis. Women arrive convinced they have cancer. Some have discovered a lump only days earlier; others have lived with symptoms for years. Many have never been taught breast awareness. Others…

In oncology, progress is measured in survival rates, response curves, and treatment gains. But those numbers rest on a quieter assumption: that health systems can deliver what science makes possible. When they cannot, progress becomes uneven—not in discovery, but in…

Global health has become very good at diagnosing problems but far less effective at implementing solutions. That gap is where Isabel Mestres has built her career. As CEO of City Cancer Challenge, she is known not as a theorist or…

As a medical student, we had a lecture on how to deliver bad news.Then, as an oncology fellow, we had it again.And as frontline clinicians, we practice it every day. “Your child has leukemia…You have cancer…Your child has Ewing sarcoma…You…

In oncology, we are trained to deliver hope alongside difficult truths. We speak about survival rates, probabilities, and outcomes. In conflict settings, those terms lose stability. What does survival mean when hospitals are destroyed, treatments cannot reach patients, and people…

A Global Summit, a Personal Reckoning At the European Society for Medical Oncology (ESMO) Leadership Summit in Singapore, discussions moved rapidly from antibody–drug conjugates to next-generation sequencing and the expanding role of immunotherapy. Clinical trial curves filled large screens, and…

When he enters the bazaar, people stand up… They stop. They smile. They love him.  This kind of love has nothing to do with titles, resources, or power. It is something far rarer. It is the quiet admiration of ordinary…

Where progress is measured not just in science, but in vision, leadership, and care. Every issue of CancerWorld explores people, policies, and practices shaping the future of oncology. In our February issue of CancerWorld, we turn our attention to leadership,…

In oncology today, innovation advances at a breathtaking pace, yet the capacity to deliver it to all who need it lags behind. Each new therapeutic frontier exposes the same paradox: the deeper our biological insight becomes, the wider the gulf…

Twenty years ago, the My Child Matters (MCM) program was launched by the Sanofi Espoir Foundation (today Foundation S). This program aimed to improve access to treatment for children and their families in low and middle-income countries (LMIC). Twenty years…